Holographic Interferometry Real Time Imaging of Refraction Index
2D Distribution and Surface Deformations in Biomedicine
N. A. Davidenko
1
, X. Zheng
2
, I. I. Davidenko
1
, V. A. Pavlov
1
, N. G. Chuprina
1
, N. Kuranda
1
,
S. L. Studzinsky
1
, A. Pandya
2
, H. Mahdi
2
, A. Ladak
2
, C. Gergely
3
, F. Cuisinier
3
and A. Douplik
2,4
1
Taras Shevchenko National University, 64/13, Volodymyrska Street, City of Kyiv, 01601, Ukraine
2
Photonics Group, Department of Physics, Ryerson University, 350 Victoria Street, Toronto, M5B 2K3, Canada
3
Université de Montpellier, 34090, Montpellier, France
4
Keenan Research Centre of the LKS Knowledge Institute, St. Michael Hospital, Toronto, M5B 1W8, Canada
Keywords: Holography, Interferometry, Imaging, Holography Interferometry, Double Exposure Holography,
Holography Interferometry Imaging, Photodynamic Therapy, Dentistry, Biomedicine.
Abstract: Holographic Interferometry of 2D Imaging of Refraction Index and Surface Deformations were recorded in
in real time video: (1) monitoring of local refraction index perturbation at accuracy of 10
-4
in transmission
mode during heat and photochemical reactions with human hemoglobin using methylene blue, protoporphyrin
IX and rhodamine as the photosensitizers and (2) monitoring in reflectance mode of human tooth local
mechanical pressure at accuracy of 10
-7
m.
1 INTRODUCTION
In this study, we explored potentials of holography
interference imaging in transmission and reflectance
modes. The transmission mode was exploited to map
the refraction index modifications inside the phantom
while the reflectance mode was employed to monitor
the surface displacement map of the human tooth.
We explored photochemical and photothermal
reaction due to interaction of light and hemoglobin at
presence of a photosensitizer. Hemoglobin was
selected as a component of blood that is the main
absorber of light in visible range. Blood is the main
oxygen supplier of biotissues and oxygen is one of the
key components of photodynamic therapy (PDT).
Blood is also a main carrier of photosensitizers (PSs)
administrated systemically – orally or intravenously.
PDT is a non-surgical treatment modality based on
photochemical reactions and administrated as a part
of clinical routine in Europe, Japan, Australia, North
and South America (Wilson B.C., Patterson, M.S.,
2008). PDT is an extremely precise and controllable
light-based therapy targeting malignant lesions,
mostly focusing on those that develop across
significant areas (e.g., esophageal cancer) or
relatively shallow depth (GI tract, prostate), or
applied as an antimicrobial therapy (Hamblin MR,
Hasan T., 2004). Within the biophotonics market
sector, PDT demonstrates the highest growth, almost
40% annually (Biophotonics Market, Tematys,
2013). Pharmaceutical companies, such as Axcan,
Parmaceuticals Inc, Nigma, Glaxo-Welcome Inc,
DUSA, Photocure, Galdderma and others have
become important players in PDT.
The physical processes involved in the PDT
interaction of laser beam and material are divided into
three parts: (1) absorption of the light energy; (2)
transformation of this energy into chemical energy
and/or into heat; (3) ultimate chemical reaction and/or
phase transformation. In some cases, it is difficult to
distinct hyperthermal and photochemical reactions,
hence in the study at the current stage we consider the
both effects taking place.
PDT is a photochemical reaction involving (1)
light, (2) photosensitive molecules (photosensitizer)
absorbing light and (3) ambient molecular oxygen
(O
2
) generating reactive oxygen species (ROS),
which in turn destroy biotissue cells or extracellular
matrix (Dougherty, T.J. et al, 1998). These include
the Type I (sensitizer-substrate) and Type II
(sensitizer-oxygen) reactions. Type II photochemical
reactions (Fig. 1) represent the transfer of light energy
to the molecular oxygen conversion into singlet
oxygen (
1
O
2
). In this study, we presume only the